At meeting held on 10 December 2014
Aurobindo Pharma announced that the Board of Directors of the Company at its meeting held on 10 December 2014, have resolved subject to the approval of the members of the Company in terms of the provisions of the Companies Act, 2013 and of other applicable laws, regulations etc., issuance of Equity Shares through a Qualified Institutions Placement (QIP") to Qualified Institutional Buyers (QIB) as per the SEBl (ICDR) Regulations, provided that the aggregate amount to be raised by issue of Securities shall not exceed a sum of US$ 350 million or Rupee equivalent thereof.At the aforesaid meeting, it has also been decided to hold a general meeting of the members of the Company for the above purpose on 21 January 2015.
Powered by Capital Market - Live News
